Phase II Evaluation of Gemcitabine- Rituximab-Oxaliplatin Combination (GROC) in Relapsed Aggressive Lymphomas

Clinical trial NCT01538641 · COMPLETED

Trial details

NCT number: NCT01538641
Sponsor: Auxilio Mutuo Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Refractory Aggressive Non-Hodgkin's Lymphoma Relapsing Aggressive Non-Hodgkin's Lymphoma

Start date: 2003-10-01
Primary completion: 2007-08-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.